Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-15 of 15
Keywords: C-reactive protein (CRP)
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Ying Tang, Xiao Ru Huang, Jun Lv, Arthur Chi-Kong Chung, Yang Zhang, Jun-Zhe Chen, Alexander J. Szalai, Anping Xu, Hui Y. Lan
Journal:
Clinical Science
Clin Sci (Lond) (2014) 126 (9): 645–659.
Published: 14 January 2014
... a mechanism of impairing the G 1 /S transition. • Importantly, finding of a blockade of CRP signalling capable of preventing AKI in CRP Tg mice is clinically significant and suggests that targeting CRP may offer a new therapy for AKI. acute kidney injury (AKI) C-reactive protein (CRP) G 1 /S...
Includes: Supplementary data
Articles
Leonard P. van der Zwan, Peter G. Scheffer, Jacqueline M. Dekker, Coen D. A. Stehouwer, Robert J. Heine, Tom Teerlink
Journal:
Clinical Science
Clin Sci (Lond) (2011) 121 (2): 71–78.
Published: 04 April 2011
...-reactive protein (CRP) inflammation myeloperoxidase (MPO) NO synthase (NOS) oxidative stress Endothelium-derived NO, which is synthesized from arginine by NOS (NO synthase), is an important regulator of vascular homoeostasis. In addition to being a powerful endogenous vasodilator, NO inhibits...
Articles
Patricia H.C. Rondó, Jesuana O. Lemos, Joilane A. Pereira, Julicristie M. Oliveira, Luiz Roberto Innocente
Journal:
Clinical Science
Clin Sci (Lond) (2008) 115 (10): 317–326.
Published: 15 October 2008
...-reactive protein (CRP) ‘Fetal programming’ or the ‘hypothesis of fetal origin of adult diseases’ suggests that stimuli or injuries that occur during the critical periods of development may permanently modify the structure, physiology or metabolism of some organs, with smaller newborns consequently...
Articles
Arschang Valipour, Martin Schreder, Michael Wolzt, Sleman Saliba, Sonja Kapiotis, Philipp Eickhoff, Otto Chris Burghuber
Journal:
Clinical Science
Clin Sci (Lond) (2008) 115 (7): 225–232.
Published: 03 September 2008
... (COPD) C-reactive protein (CRP) systemic inflammation vascular endothelial growth factor VEGF) VEGF (vascular endothelial growth factor), a soluble heparin-binding glycoprotein, is a cytokine with potent angiogenic properties, enhancing vascular permeability and modulating thrombogenicity [ 1...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2007) 113 (2): 79–81.
Published: 13 June 2007
... indicate that low-grade inflammatory activity might influence cytokine production in these patients. © The Authors Journal compilation © 2007 Biochemical Society 2007 C-reactive protein (CRP) cytokine inflammation insulin resistance interleukin lipopolysaccharide Type 2 diabetes...
Articles
Giovanna Castoldi, Stefania Galimberti, Chiara Riva, Ruggero Papagna, Federico Querci, Marco Casati, Gianpaolo Zerbini, Gianluigi Caccianiga, Carlo Ferrarese, Marco Baldoni, Maria Grazia Valsecchi, Andrea Stella
Journal:
Clinical Science
Clin Sci (Lond) (2007) 113 (2): 103–108.
Published: 13 June 2007
..., might induce a ‘low-grade’ inflammation state through the stimulation of different cytokines [ 4 – 6 ]. C-reactive protein (CRP) cytokine inflammation insulin resistance interleukin lipopolysaccharide Type 2 diabetes Many ‘pro-inflammatory’ molecules have been proposed as potential...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2007) 112 (11): 543–555.
Published: 01 May 2007
...-reactive protein (CRP) cytokine exercise inflammation vascular wall It is well established that physically fit individuals have a reduced risk of developing CVD (cardiovascular disease) and other age-related chronic disorders [ 1 ]. However, the mechanisms responsible for the protective effects...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2007) 112 (8): 449–456.
Published: 13 March 2007
...-reactive protein (CRP) heart rate variability inflammation stress Vagal efferent control of HR (heart rate) is an important index of adaptive neurocardiac regulation. Among patients with CAD (coronary artery disease), vagal HR control is well known to exert a cardioprotective effect [ 1...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2007) 112 (5): 305–314.
Published: 01 February 2007
... The Biochemical Society 2007 C-reactive protein (CRP) cytokine interleukin musculoskeletal disorder overuse injury tumour necrosis factor (TNF) upper-body musculoskeletal assessment Despite epidemiological evidence linking the onset and severity of MSDs to repetitive and forceful tasks [ 2 , 3...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2005) 108 (6): 493–495.
Published: 24 May 2005
... that can be inhibited by pitavastatin. Correspondence: Dr Subodh Verma (email [email protected] ). 15 3 2005 22 3 2005 30 3 2005 30 3 2005 The Biochemical Society 2005 atherosclerosis C-reactive protein (CRP) interleukin-8 mitogen-activated protein kinase...
Articles
Eun-Jung RHEE, Won-Young LEE, Se-Yeon KIM, Byung-Jin KIM, Ki-Chul SUNG, Bum-Su KIM, Jin-Ho KANG, Ki-Won OH, Eun-Sook OH, Ki-Hyun BAEK, Moo-Il KANG, Hee-Yeon WOO, Hyo-Soon PARK, Sun-Woo KIM, Man-Ho LEE, Jung-Roe PARK
Journal:
Clinical Science
Clin Sci (Lond) (2005) 108 (3): 237–243.
Published: 18 February 2005
... to be investigated further. Correspondence: Dr Won-Young Lee (email [email protected] ). 26 8 2004 19 11 2004 29 11 2004 29 11 2004 The Biochemical Society 2005 atherosclerosis coronary artery disease C-reactive protein (CRP) left ventricular mass index osteoprotegerin...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2005) 108 (2): 121–128.
Published: 21 January 2005
...-diabetic patients, which may only partly be explained by traditional risk factors. Our purpose was to compare non-traditional risk factors, such as endothelial function, C-reactive protein (CRP) and adiponectin, in Type II diabetic and non-diabetic patients following AMI (acute myocardial infarction...
Articles
Marta ESCRIBANO-BURGOS, Antonio LÓPEZ-FARRÉ, María del MAR GONZÁLEZ, Carlos MACAYA, Antonio GARCÍA-MÉNDEZ, Petra J. MATEOS-CÁCERES, Sergio ALONSO-ORGAZ, Carolina CARRASCO, Luis A. RICO, Juan Carlos PORRES CUBERO
Journal:
Clinical Science
Clin Sci (Lond) (2005) 108 (1): 85–91.
Published: 15 December 2004
... such as TNF-α. Correspondence: Dr Juan Carlos Porres Cubero (email [email protected] ). 23 7 2004 22 9 2004 24 9 2004 24 9 2004 The Biochemical Society 2005 CD32 receptor C-reactive protein (CRP) endothelium endothelial nitric oxide synthase (eNOS) inflammation...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2004) 106 (5): 443–445.
Published: 01 May 2004
... (e-mail [email protected] ). 19 1 2004 26 1 2004 26 1 2004 © 2004 The Biochemical Society 2004 C-reactive protein (CRP) cytokine endothelial function inflammation serum secretory non-pancreatic type II phospholipase A2 (sPLA2) Clinical Science (2004) 106...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2004) 106 (5): 511–517.
Published: 01 May 2004
... The Biochemical Society 2004 coronary artery disease C-reactive protein (CRP) endothelial function forearm blood flow inflammation secretory non-pancreatic type II phospholipase A2 (sPLA2) Clinical Science (2004) 106, 511 517 (Printed in Great Britain) 511 Elevated secretory non-pancreatic type II...